The PassMachine Consultation-Liaison Psychiatry Board Review 2020

The PassMachine Consultation-Liaison Psychiatry Board Review 2020

‘‘Here’s the challenge: this Consultation-Liaison Psychiatry review features 50.5 hours of laser-focused lectures and 900+ Q Bank questions, but all that great content means nothing if you don’t get through it in time for the exam. So, Beat The Boards! makes your prep easy

Intended Audience: Psychiatrists

Learning Objectives:
Upon completion of this program, participants should be able to conduct, discuss, and describe:

• – Assessment and screening of eating and feeding disorders
• – Assessment and management of psychosomatic aspects of select heart diseases and psychiatric syndromes in heart disease
• – Management of substance-related and addictive disorders
• – Normal sexual function and age-related changes, general assessment and management approaches for sexual dysfunctions, gender dysphoria, paraphilic disorders
• ‘‘Here’s The Challenge: this Consultation-Liaison Psychiatry review features 50.5 hours of laser-focused lectures and 900+ Q Bank questions, but all that great content means nothing if you don’t get through it in time for the exam. So, Beat The Boards! makes your prep easy

Intended Audience: Psychiatrists

Learning Objectives:

• Upon completion of this program, participants should be able to conduct, discuss, and describe:
• – Assessment and screening of eating and feeding disorders
• – Assessment and management of psychosomatic aspects of select heart diseases and psychiatric syndromes in heart disease
• – Management of substance-related and addictive disorders
• – Normal sexual function and age-related changes, general assessment and management approaches for sexual dysfunctions, gender dysphoria, paraphilic disorders

• – 01A Psychiatric Disorders in Chronic Kidney Disease I
• – 01B Psychiatric Disorders in Chronic Kidney Disease II
• – 01C Psychiatric Disorders in Chronic Kidney Disease III
• – 02A Neurology I- Cortical Syndromes
• – 02B Neurology II- Movement Disorders & Stroke
• – 02C Neurology III- Seizures & Headaches
• – 03A Endocrine I- Diabetes Mellitus
• – 03B Endocrine II- Thyroid and Parathyroid Diseases
• – 03C Endocrine III- Parathyroid and Adrenal Diseases, Pheochromocytoma, and Osteoporosis
• – 03D Endocrine IV- Assessment and Management of Psychosomatic Aspects of Select Endocrine Diseases
• – 04A Surgery and Surgical Critical Care I- Role of Psychiatrist and Preoperative Psychiatric Evaluations
• – 04B Surgery and Surgical Critical Care II- Preoperative and Perioperative Issues
• – 04C Surgery and Surgical Critical Care III- Postoperative Issues, Management of Psychiatric Disorders on Surgical and Intensive Care Units, ICU Delirium, and Burn Patients
• – 05A Obstetrics and Gynecology I- Introduction to Obstetrics and Gynecology and Psychiatric Comorbidities in OB_GYN Diseases
• – 05B Obstetrics and Gynecology II- Assessment and Management of Psychosomatic Aspects of Select OB_GYN Conditions
• – 05C Obstetrics and Gynecology III- Assessment and Management of Psychosomatic Aspects of Select OB_GYN Conditions
• – 06 Rheumatology
• – 07A Dermatology I- General Assessment Approaches, General Management Approaches, and Dermatologic Manifestations of Psychiatric Disorders
• – 07B Dermatology II- Psychological Factors in Dermatologic Diseases and in Their Treatment, Factitious Disorders, and Prescribing Guidelines
• – 08A Heart I- Assessment and Management of Psychosomatic Aspects of Select Heart Diseases and Psychiatric Syndromes in Heart Disease
• – 08B Heart II- Psychological Factors in Heart Disease and its Treatment and Psychiatric Assessment in the Context of Heart Disease
• – 08C Heart III- Psychiatric Management in the Context of Heart Disease and Prescribing Guidelines
• – 09A Pain I- Introduction, Epidemiology of Pain Conditions and Scope of Pain-killer Epidemic, Neurobiology, Cognitive and Emotional Factors
• – 09B Pain II- Pain Assessment_Pain Scales and Assessment and Management of Psychosomatic Aspects of Select Pain Conditions
• – 09C Pain III- Psychiatric Comorbidities and Differential Diagnoses, Pharmacologic and Other Somatic Interventions, Psychosocial Treatment Interventions, and Other Topics
• – 10A Transplant Psychiatry I- Pre-transplant Evaluation
• – 10B Transplant Psychiatry II- Post-transplant Management
• – 11A Palliative Medicine I- Introduction to Palliative Medicine and Managing Psychiatric Disorders in the Palliative Setting
• – 11B Palliative Medicine II- Psychological Interventions, Spirituality, Working with Families, Interdisciplinary Issues, Grief, Grief Therapy, and Bereavement
• – 12A Pulmonary Disorders I- Assessment and Management of Psychosomatic Aspects of Select Pulmonary Diseases
• – 12B Pulmonary Disorders II- Assessment and Management of Psychosomatic Aspects of Select Pulmonary Diseases
• – 12C Pulmonary Disorders III- Psychiatric Assessment and Management in the Context of Pulmonary Disease
• – 13A Gastrointestinal Disorders I- Assessment and Management of Select GI Syndromes
• – 13B Gastrointestinal Disorders II- Hepatitis, Drug Induced Liver Disease and Liver Transplantation
• – 13C Gastrointestinal Disorders III- Pancreatic Disorders, Psychiatric Management in Liver Disease and Psychological Factors in GI Diseases
• – 14A Legal Issues- Part I
• – 14B Legal Issues- Part II
• – 15 Ethics and Practice Issues
• – 16A Psychoncology I- Psychiatric Syndromes Present in Cancer, Psychological Factors in Cancer and in its treatment, and Psychiatric Assessment
• – 16B Psychoncology II- Psychiatric Management in the Context of Cancer, Medication Use and Adverse Effects in Context of Cancer and Psychiatric Morbidity
• – 17A Pediatric Psychiatry I- General Psychiatric Assessment and Management Approaches
• – 17B Pediatric Psychiatry II- Assessment and Management of Psychosomatic Aspects of Select Pediatric Conditions and Prescribing Guidelines- Psychiatric Management In Context of Neurologic Diseases
• – 18A Psychosomatic Topics in Physical Medicine and Rehabilitation I- Introduction, Traumatic Brain Injury, and Principles of Cognitive Rehabilitation
• – 18B Psychosomatic Topics in Physical Medicine and Rehabilitation II- Spinal Cord Injury, Paralysis, and Neuromuscular Condition
• – 19 Special Topics for the Psychosomatic Medicine Course
• – 20A Hematology I
• – 20B Hematology II
• – 21A HIV_AIDS I- Basic Pathophysiology, Diagnosis, and Assessment
• – 21B HIV_AIDS II- Psychiatric Management
• – 21C HIV_AIDS III- Relevant Psychological Factors and Pharmacologic Issues
• – 22A Chronic Fatigue Syndrome I- Basic Pathophysiology, Diagnosis, and Assessment
• – 22B Chronic Fatigue Syndrome II- Relevant Psychological Factors, Psychiatric Management, and Pharmacologic Issues
• – 23 Fibromyalgia Syndrome
• – 24A Assessment I- Consultation Overview, Cultural and Spiritual Issues
• – 24B Assessment II- Neuroimaging
• – 24C Assessment III- Neuropsychological Testing
• – 25A Delirium- Part I
• – 25B Delirium- Part II
• – 26A Neurocognitive Disorders I- Diagnostic Criteria and Classification
• – 26B Neurocognitive Disorders II- Diagnostic Assessment
• – 26C Neurocognitive Disorders III- General Management
• – 26D Neurocognitive Disorders IV- Review of Alzheimer’s Disease
• – 26E Neurocognitive Disorders V- Review of Lewy Body and Vascular Disease
• – 26F Neurocognitive Disorders VI- Review of Frontal Temporal NCD and Infectious Diseases
• – 26G Neurocognitive Disorders VII- Review of Other Etiologies
• – 27 Psychological Reactions to Illness
• – 28A Depressive Disorders 1- Clinical Overview & Pathophysiology
• – 28B Depressive Disorders 2- Diagnosis and Assessment
• – 28C Depressive Disorders 3- Treatment Overview and SSRIs _SNRIs
• – 28D Depressive Disorders 4- Antidepressants and ECT
• – 28E Depressive Disorders 5- Somatic Treatments and Psychotherapies
• – 29A Bipolar Disorders I- Bipolar Disorder Diagnosis, Assessment of Bipolar Disorders and Secondary Bipolar Disorders
• – 29B Bipolar Disorders II- Bipolar Disorders in Specific Medical Populations and Management of Bipolar Disorders
• – 30A Suicide
• – 30B Violence and Aggression
• – 31A Schizophrenia Spectrum Disorders and Psychosis I- Epidemiology and Etiologies of Psychosis
• – 31B Schizophrenia Spectrum Disorders and Psychosis II- Assessment in the Medically Ill and Psychosis in Specific Medical Populations
• – 31C Schizophrenia Spectrum Disorders and Psychosis III- Review of Catatonic Syndrome and Catatonic Syndrome in Specific Medical Populations
• – 31D Schizophrenia Spectrum Disorders and Psychosis IV- Review of Specific Schizophrenia Spectrum Disorders and Specific Management Considerations of Psychosis in the Medically Ill
• – 32A Anxiety Disorders I- Anxiety Mechanisms and Evaluation
• – 32B Anxiety Disorders II- Review of Specific Anxiety Disorders
• – 32C Anxiety Disorders III- Secondary Anxiety Disorders
• – 32D Anxiety Disorders IV- Anxiety Presentations in Specific Medical Populations
• – 32E Anxiety Disorders V- Management of Anxiety
• – 32F Anxiety Disorders VI- Post Traumatic Stress Disorder
• – 33A Somatic Symptom and Related Disorders
• – 33B Factitious Disorder and Malingering
• – 34A Eating and Feeding Disorders I- Overview of Eating and Feeding Disorders and Assessment and Screening
• – 34B Eating and Feeding Disorders II- Review of Specific Eating and Feeding Disorders- Diagnostic and Clinical Presentations, Epidemiology and Etiologies, Assessment and Management
• – 34C Eating and Feeding Disorders III- Specific Eating & Feeding Disorders- Diagnostic & Clinical Presentations, Epidemiology & Etiologies, Assessment & Management and Eating
• – 35A Sleep-Wake Disorders I
• – 35B Sleep-Wake Disorders II
• – 36A Sexual Dysfunctions, Gender Dysphoria, Paraphilic Disorders I- Normal Sexual Function and Age-Related Changes, General Assessment Approaches and General Management Approaches
• – 36B Sexual Dysfunctions, Gender Dysphoria, Paraphilic Disorders II- Specific Sexual Dysfunction Disorders, Specific Medical Populations, Gender Dysphoria and Paraphilic Disorders
• – 37A Substance-related and Addictive Disorders I- Overview of Substance Related Disorders and Assessment in the Medically Ill
• – 37B Substance-related and Addictive Disorders II- Review of Alcohol – Sedative Use Disorders
• – 37C Substance-related and Addictive Disorders III- Review of Opioid Use Disorders and Review of Stimulant Use Disorders
• – 37D Substance-related and Addictive Disorders IV- Nicotine Use Disorders, Cannabis Use Disorders, Other Drugs of Abuse and Impaired Health Care Providers
• – 38A Psychopharmacology I- Pharmacokinetics
• – 38B Psychopharmacology II- Pharmacodynamics
• – 38C Psychopharmacology III- Adverse Drug Reactions and Pregnancy-Related Issues
• – 38D Psychopharmacology IV- Prescribing Cautions and Drug-Drug Interactions